FindTrial
Sign In

Effect of gene polymorphism on fentanyl individual variation

Effect of gene polymorphism on fentanyl individual variation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15005962
Enrollment
Unknown
Registered
2015-02-10
Start date
2015-02-11
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

Case series:Nil

Sponsors

The Third Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists (ASA) physical status I-III; no chronic treatment with drugs that act on neuropathic pain; No antidepressant or anticonvulsant medications, nonsteroidal anti-inflammatory drugs, or opioid.

Exclusion criteria

Exclusion criteria: Chronic treatment with drugs that act on neuropathic pain; Patients taking antidepressant or anticonvulsant medications, nonsteroidal anti-inflammatory drugs, or opioid analgesics; Patients with severe hepatic or renal impairment, or history of diabetes; or allergies to any of the used drugs.

Design outcomes

Primary

MeasureTime frame
gene type;fentanyl dose;—

Countries

China

Contacts

Public ContactHu Jie
1449208030@qq.com+86 15084794021

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026